Table 2. Correlations and associations between adiponectin and cardiovascular risk factors.
Characteristics | p | ||
Age | 0.16 | 0.005 | |
Sex | Male | 4.7 (2.9–6.6) | <0.0001 |
Female | 6.9 (4.1–10.1) | ||
Body mass index (kg/m2) | −0.26 | <0.0001 | |
Actual hypertension | Yes | 5.0 (2.9–7.5) | 0.13 |
No | 5.1 (3.4–8.1) | ||
History of diabetes mellitus | Yes | 4.2 (2.2–8.3) | 0.37 |
No | 5.0 (3.1–7.7) | ||
Actual smoker | Yes | 3.9 (2.4–5.7) | 0.02 |
No | 5.3 (3.2–7.9) | ||
Family history of CAD | Yes | 4.3 (2.5–7.5) | 0.05 |
No | 5.3 (3.4–7.9) | ||
LDL-cholesterol (mg/dl) | 0.09 | 0.11 | |
HDL-cholesterol (mg/dl) | 0.32 | <0.0001 | |
Triglycerides (mg/dl) | −0.32 | <0.0001 | |
High-sensitivity CRP (mg/dl) | −0.04 | 0.49 | |
Pericardial adipose tissue (ml) | −0.24 | <0.0001 | |
Total number of coronary artery plaques | −0.21 | 0.0004 | |
Number of calcified plaques | −0.05 | 0.39 | |
Number of mixed plaques | −0.20 | 0.0007 | |
Number of non-calcified plaques | −0.18 | 0.003 |
Values are presented as correlation coefficient or median (interquartile range).
Age (r = 0.38, p<0.0001) and HDL-cholesterol (r = −0.21, p = 0.0003) as internal controls of our data were significantly correlated with total plaque burden in bivariate analysis.